US OptionsDetailed Quotes
LLY241206C755000
- 56.07
- +13.60+32.02%
15min DelayTrading Dec 3 09:49 ET
56.07High51.15Low
51.15Open42.47Pre Close11 Volume45 Open Interest755.00Strike Price57.53KTurnover0.00%IV-0.48%PremiumDec 6, 2024Expiry Date59.98Intrinsic Value100Multiplier3DDays to Expiry0.00Extrinsic Value100Contract SizeAmericanOptions Type--Delta--Gamma13.43Leverage Ratio--Theta--Rho--Eff Leverage--Vega
Eli Lilly and Co Stock Discussion
Probably last chance to get out before the sinking!
Don’t Miss The Wave 🌊 🏄♂️
STOCKS WITH AMAZING ROI %
$Vistra Energy (VST.US)$ is overlooked but outperformed most stocks in 2024
$NVIDIA (NVDA.US)$ as well as
SEZL DAVE LBPH ROOT SMR APP SUMMIT LUNR MSTR
.
Historic 2 Weeks Nov 25-29 December 2-7
• TOP TIER
BTC to $100K *
ETH to $4,000 *
NOW to $1041
LLY to $788.19
BRK.B to $483 *
MSFT to $423
PANW to $384.37
CRWD to $347.59
TSLA to $333 *
APP to $328.5...
I suspect they chose not to present the full safety profile, given that the weight loss results for the 120 mg and 280 mg QM cohorts, in obese non-diabetics (without dose escalations), at week 16 in P2 are consistent with the P1 results (see slide 1). So, it is likely that the 120 mg and 280 mg QM (without dose...
If you can't tell yet that something smells fishy for the timing of the WSJ news about Biden passing law for Medicare accepting fatloss drug on holiday week. Then you deserve what is going to happen next.
It’s unusual for a major policy like expanding Medicare and Medicaid to cover weight-loss drugs to be proposed 30 days before a presidential term ends. Such changes require legislative approval or regulatory adjustments, both of w...
No comment yet